(Q48289941)

English

Prime and boost immunization with influenza and adenovirus encoding the Toxoplasma gondii surface antigen 2 (SAG2) induces strong protective immunity

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20189485

Prime and boost immunization with influenza and adenovirus encoding the Toxoplasma gondii surface antigen 2 (SAG2) induces strong protective immunity (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20189485

Toxoplasma gondii

0 references

0 references

1 reference

based on heuristic

inferred from title

Cristiana C. Garcia

6

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20189485

Oscar Bruna-Romero

7

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20189485

Ricardo Gazzinelli

9

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20189485

Alexandre Vieira Machado

object named as

Alexandre V Machado

1

0 references

author name string

Bráulia C Caetano

2

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20189485

Rafael P Barbosa

3

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20189485

Ana Paula C Salgado

4

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20189485

Renata H Rabelo

5

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20189485

Nicolas Escriou

8

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20189485

language of work or name

0 references

publication date

26 February 2010

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20189485

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20189485

28

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20189485

18

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20189485

3247-3256

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20189485

Vaccination greatly reduces disease, disability, death and inequity worldwide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

Parasite vaccines: the new generation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

Importance of CD8 T cell-mediated immune response during intracellular parasitic infections and its implications for the development of effective vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

The role of Toll-like receptors in the host response to viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

Toll or toll-free adjuvant path toward the optimal vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

Innate sensors of influenza virus: clues to developing better intranasal vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

Activation of toll-like receptor signaling pathway for protection against influenza virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

A decade after the generation of a negative-sense RNA virus from cloned cDNA - what have we learned?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

Emerging role of dendritic cells in respiratory viral infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

Induction of protective immunity against malaria by priming-boosting immunization with recombinant cold-adapted influenza and modified vaccinia Ankara viruses expressing a CD8+-T-cell epitope derived from the circumsporozoite protein of Plasmodium y

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

Characterization ofin VivoPrimary and Secondary CD8+T Cell Responses Induced by Recombinant Influenza and Vaccinia Viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

Hyperattenuated recombinant influenza A virus nonstructural-protein-encoding vectors induce human immunodeficiency virus type 1 Nef-specific systemic and mucosal immune responses in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

Amplification, expression, and packaging of foreign gene by influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

RNA polymerase I-mediated expression of influenza viral RNA molecules

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

Mutations in the nonconserved noncoding sequences of the influenza A virus segments affect viral vRNA formation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

Influenza A virus RNA polymerase has the ability to stutter at the polyadenylation site of a viral RNA template during RNA replication

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

Highly conserved regions of influenza a virus polymerase gene segments are critical for efficient viral RNA packaging.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

Specific residues of the influenza A virus hemagglutinin viral RNA are important for efficient packaging into budding virions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

Importance of both the coding and the segment-specific noncoding regions of the influenza A virus NS segment for its efficient incorporation into virions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

Selective incorporation of influenza virus RNA segments into virions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

Expression of a foreign gene by stable recombinant influenza viruses harboring a dicistronic genomic segment with an internal promoter

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

Recombinant influenza A viruses harboring optimized dicistronic NA segment with an extended native 5' terminal sequence: induction of heterospecific B and T cell responses in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

Toxoplasmic encephalitis in AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

Cell-mediated immunity to Toxoplasma gondii develops primarily by local Th1 host immune responses in the absence of parasite replication

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

Development of a vaccine for toxoplasmosis: current status

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

Immunization with E. coli produced recombinant T. gondii SAG1 with alum as adjuvant protect mice against lethal infection with Toxoplasma gondii

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

Protective immunity against congenital toxoplasmosis with recombinant SAG1 protein in a guinea pig model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

Immunization with a DNA plasmid encoding the SAG1 (P30) protein of Toxoplasma gondii is immunogenic and protective in rodents

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

Vaccination with replication-deficient recombinant adenoviruses encoding the main surface antigens of toxoplasma gondii induces immune response and protection against infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

Induction of cytotoxic T-cell response against hepatitis C virus structural antigens using a defective recombinant adenovirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

A new approach to an influenza live vaccine: modification of the cleavage site of hemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

Enhanced cellular immune responses to SIV Gag by immunization with influenza and vaccinia virus recombinants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

Enhanced CD8+ T cell response to HIV-1 env by combined immunization with influenza and vaccinia virus recombinants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

Recombinant viruses expressing a human malaria antigen can elicit potentially protective immune CD8+ responses in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

Prime-boost immunization schedules based on influenza virus and vaccinia virus vectors potentiate cellular immune responses against human immunodeficiency virus Env protein systemically and in the genitorectal draining lymph nodes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

Induction of cellular immune responses to simian immunodeficiency virus gag by two recombinant negative-strand RNA virus vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

Jump-starting the immune system: prime-boosting comes of age.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

Differential role of TLR- and RLR-signaling in the immune responses to influenza A virus infection and vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

Toll-like receptor-mediated activation of neutrophils by influenza A virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by Toll-like receptor signalling.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

Cutting edge: innate immune response triggered by influenza A virus is negatively regulated by SOCS1 and SOCS3 through a RIG-I/IFNAR1-dependent pathway.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

Subversion of innate and adaptive immune responses by Toxoplasma gondii

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

A GRA1 DNA vaccine primes cytolytic CD8(+) T cells to control acute Toxoplasma gondii infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

Protective immunity induced by vaccination with SAG1 gene-transfected cells against Toxoplasma gondii-infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

B cells are essential for vaccination-induced resistance to virulent Toxoplasma gondii

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

Decreased resistance of B cell-deficient mice to infection with Toxoplasma gondii despite unimpaired expression of IFN-gamma, TNF-alpha, and inducible nitric oxide synthase.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

Immunopathogenesis of toxoplasmosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

Protozoan encounters with Toll-like receptor signalling pathways: implications for host parasitism.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

Mucosal defences against orally acquired protozoan parasites, emphasis on Toxoplasma gondii infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

Lamina propria CD4+ T lymphocytes synergize with murine intestinal epithelial cells to enhance proinflammatory response against an intracellular pathogen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

Toxoplasma gondii and mucosal immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

Mucosal immune response in toxoplasmosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

Mucosal immunity in Toxoplasma gondii infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

Chimeric influenza virus induces neutralizing antibodies and cytotoxic T cells against human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.02.003

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2010.02.003

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20189485

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/20189485

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48289941&oldid=2194319450"